awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33388089-28F9A1C3-3600-4816-99D6-D7FC331126E6
Q33388089-28F9A1C3-3600-4816-99D6-D7FC331126E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33388089-28F9A1C3-3600-4816-99D6-D7FC331126E6
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.
P2860
Q33388089-28F9A1C3-3600-4816-99D6-D7FC331126E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33388089-28F9A1C3-3600-4816-99D6-D7FC331126E6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8fab9feec1da18d9f774dfc494797cf02c9566e
P2860
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.